AIDS

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	108
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	76
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	51
Real world use of dolutegravir two drug regimens	46
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	44
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research	44
Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum	43
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	41
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	39
Cerebral toxoplasmosis in the twenty-first century: long-term clinical outcomes in a retrospective cohort study in the Netherlands	37
Trends in population HIV viral suppression: a longitudinal analysis	36
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	32
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	32
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	31
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	31
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	31
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	29
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	28
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	28
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy	27
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	27
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	27
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	27
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease	27
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	27

Life expectancy of people with HIV on antiretroviral therapy in Spain	26
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	26
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	26
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	26
A point-of-care tenofovir urine test improves accuracy of self-reported preexposure prophylaxis adherence and increases condomless sex reporting among young women	25
Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV	25
Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions	25
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors	24
Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease	23
The relationship between alcohol consumption and risk of HIV in married men in Sub-Saharan Africa	22
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen	22
Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?	21
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV	21
Association between low bone mass and fracture prevalence among children living with HIV in Africa	21
Fatty liver disease in children living with HIV: a ghostly iceberg	20
Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV	20
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?	20
‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence	20
Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985–2019	19
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings	19
HIV and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex in rural South Africa	19
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV	19
Not all costs are the same: understanding costs of opioid agonist treatment around the world	18
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi	18
Metabolic dysfunction-associated steatotic liver disease and liver fibrosis in people with HIV	18
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort	18
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the prerandomisation phase of a clinical trial	18
Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV	17
Incident depression among Medicare beneficiaries with disabilities and HIV	17
Increased risk of false-positive HIV ELISA results after COVID-19	17
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV	17
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa	17
Ambient air pollution is associated with vascular disease in Ugandan HIV-positive adolescents	17
Age-associated dementia among older people aging with HIV in the United States: a modeling study	17
An agricultural livelihood intervention is associated with reduced HIV stigma among people with HIV	17
Sexually transmitted infections in the preexposure prophylaxis era	17
Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support	16
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial	16
Higher CCR5 density on CD4+ T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission	16
Local microbiota dysbiosis contributes to the development of high-risk human papillomavirus-associated anal squamous cell carcinoma	16
Addressing atherosclerotic cardiovascular disease risk in persons with HIV	16
Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia	16
What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes	15
Prevalence and incidence of human papilloma virus-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people with HIV	15
Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre	15
‘With age comes wisdom’: effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV	15
An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis	15
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection	15
Coordination of inflammatory responses in children with perinatally acquired HIV infection	15
Predictors of intact HIV DNA levels among children in Kenya	14

Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis	14
Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic	14
Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries	14
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017	14
High body mass and depression accelerate physical decline in people with HIV - can exercise reverse the clock?	14
Bictegravir/emtricitabine/tenofovir alafenamide after virologic failure to cabotegravir/rilpivirine	14
The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multi-site cohort study	14
HIV and race are independently associated with endothelial dysfunction	14
Endoplasmic reticulum stress-induced goblet cell apoptosis might contribute to intestinal barrier damage in asymptomatic people living with HIV	14
Prevalence and resistance patterns of Mycoplasma genitalium infection in people with HIV: a systematic review and meta-analysis	14
Poverty and protection: the relationship between multidimensional poverty, social protection interventions, and HIV viral load	13
The cumulative prevalence of HIV-1 drug resistance in perinatal HIV	13
Racial/ethnic disparities in estimated undiagnosed HIV infection among adolescents and adults in the United States, 2017–2021	13
Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation	13
Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes	13
Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation	13
Association of CD4+ cell count and HIV viral load with risk of non-AIDS-defining cancers	13
Altered mitochondrial mass and fatty acid uptake by natural killer cells in HIV-exposed uninfected children at 6 years of age	13
Validity of competing algorithms to identify people with HIV in Medicaid administrative claims: a statewide analysis	13
The relationship between HIV and reading performance for children in Tanzania	13
Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence	13
Obesity in HIV infection: host-pathogen interaction	13
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort	13
A note of thanks to our reviewers	13
Brain N-acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIV	13
Global health solidarity in the HIV and hypertension disease response	12
Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus	12
Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response	12
Hepatitis B core antibody positivity and risk of hepatitis B reactivation following switch of antiretroviral therapy	12
Caregiver fears and assumptions about child HIV status drive not testing children for HIV	12
A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders	12
Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection	12
Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy	12
Risk score prediction for bacteriologically confirmed tuberculosis among adults with HIV on antiretroviral therapy in northwest Ethiopia: prognostic model development	12
Dolutegravir regimens have transformed treatment, but ongoing drug resistance research is required to maintain success	12
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection	12
Adolescent girls and young adult women's HIV infection, male partner age, and HIV status: connecting the dots	12
Is it time to retire efavirenz as a first-line option worldwide?	12
Children who are HIV-exposed and uninfected: evidence for action	12
Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study	12
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America	12
Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally	12
Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study	12
When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV	12
Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?	12
Initial antiretroviral therapy regimen and risk of heart failure: Erratum	11
Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe	11
COVID-19 in Africa: preexisting immunity and HIV	11
Cervical cancer screening in women with HIV: an audit of clinical care	11
Risk and predictors of penile cancer in US Veterans with HIV	11
Auditory and cognitive function in older adults living with and without HIV	11
Racial disparities in cancer risk among MSM with HIV in the United States	11
Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV	11
HIV-positive Ukrainian refugees in the Czech Republic	11
Housing is harm reduction	11
Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston	11
Associations between HIV serostatus and coronary artery plaque volume progression	11
First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort	11
Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs	10
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period	10
Fungal diseases are not in the radar of main international HIV conferences	10
Transformative potential of artificial intelligence in US CDC HIV interventions: balancing innovation with health privacy	10
HIV-positive donor hearts – a game changer for patients with HIV and organ failure?	10
Global variations in pubertal growth spurts in adolescents living with perinatal HIV	10
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV	10
Identification of a novel HIV-1 second-generation circulating recombinant form (CRF136_0107) among MSM in China	10
Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa	10
Epstein–Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS	10
Deciphering HIV vaccine-induced antibody response according to ethnicity	10
HIV and mpox: a rapid review	10
Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States	10
The incidence and dynamic risk factors of chronic kidney disease among people with HIV	10
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV	10
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV	10
Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption	10
Factors associated with survival in patients with lymphoma and HIV	10
Home-based HIV testing strategies for middle-aged and older adults in rural South Africa	10
Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis	10
Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV	9
Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk	9

Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3	9
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression	9
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?	9
Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy	9
The application of new metrics for understanding trends in undiagnosed HIV among key populations	9
Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats	9
Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes	9
The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa	9
Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV	9
Transplantation of kidneys from donors with HIV: are we there yet?	9
Impact of a livelihood intervention on gender roles and relationship power among people with HIV	9
Addressing the burden of HIV-associated chronic lung disease in West Africa	9
Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015–2020	9
Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum	9
Abnormal cognitive aging in people with HIV: evidence from data integration between two countries’ cohort studies	9
Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population	9
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIV	9
Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action	9
Food insecurity likely contributes to frailty in people with HIV	9
Cytokines in HIV infection: authors’ reply	9
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes	9
Self-injurious unnatural death among Veterans with HIV	9
The HIV-2 proviral landscape is dominated by defective proviruses	9
Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China	8
Incidence of high blood pressure among Kenyan adults with HIV	8
Care interruptions and mortality among adults in Europe and North America	8
New preexposure prophylaxis options need updated counseling approaches: reframing ‘risk’ in HIV prevention counseling for young sexual and gender minorities of color	8
The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV	8
Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?	8
Assessing layered HIV prevention programming: optimizing outcomes for adolescent girls and young women	8
On the compounding manifestations of racism shaping the US HIV/AIDS epidemic: why ending the HIV epidemic must address these factors for success	8
Sparse data obscure an unchecked Russian HIV epidemic	8
Plasma d-amino acids are associated with markers of immune activation and organ dysfunction in people with HIV	8
Dolutegravir-induced neural tube defects in mice are folate responsive	8
Years of life lost to cancer among the United States HIV population, 2006–2015	8
Cabotegravir–rilpivirine treatment initiation in a nonvirologically suppressed patient	8
Contribution of HIV transmission bursts to future HIV infections	8
Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation	8
Risk factors of incident physical frailty in middle-aged and older people with and without HIV: evidence from the CHART cohort	8
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa	8
Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific	8
Clinical decision support systems to guide healthcare providers on HIV testing	8
Initial antiretroviral therapy regimen and risk of heart failure	8
Maternal–foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection	8
Baseline HIV drug-resistance testing: 12 US jurisdictions, 2014–2019	8
Brain aging and cardiovascular factors in HIV: a longitudinal volume and shape MRI study	8
Persistent immunological repercussions of late antiretroviral initiation in children living with HIV	8
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy	8
Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries	8
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice	7
AIDS: changes in leadership	7
Keeping up with Streptococcus pneumoniae in children living with HIV	7
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment	7
Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors’ reply	7
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	7
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	7
Cost of improved test and treat strategies in Indonesia	7
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	7
Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa	7
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV	7
Immediate virological failure with intramuscular cabotegravir–rilpivirine in a patient long suppressed with dolutegravir–rilpivirine	7
Deconvoluting the contribution of antiretroviral choice in weight gain	7
Sexual behaviours and risk with women in MSM in sub-Saharan Africa	7
Human herpes virus 8-related illness: still with us	7
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy	7
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	7
Weight loss associated with semaglutide treatment among people with HIV	7
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns	7
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV	7
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa	7
Association between tight junction proteins and cognitive performance in untreated persons with HIV	7
Differential genome-wide associated variants and enriched pathways of ECG parameters among people with versus without HIV	7
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV	7
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	7
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey	7
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens	7
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	7
Association between HIV and cancer risk	7
Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa	7
The future of HIV: challenges in meeting the 2030 Ending the HIV Epidemic in the US (EHE) reduction goal	6
A predictive model for HIV-related lymphoma	6
Partnering with traditional healers to increase HIV testing in Senegal, West Africa	6
Universal HIV screening in the emergency department: an interrupted time series analysis	6
Leveraging social networks for identification of people with HIV who are virally unsuppressed	6
Arterial stiffness in people with HIV: a cross-sectional, comparative study with echocardiographic outcomes in Tanzania	6
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability	6
Improving HIV preexposure prophylaxis uptake with artificial intelligence and automation: a systematic review	6
Cytomegalovirus: 40 years and still the major viral cofactor in HIV infection	6
Cancer risk among HIV-exposed uninfected children in the United States	6
Differential survival of Brazilian patients with diffuse large B-cell lymphoma with and without HIV infection	6
Insta-PrEP: improving PrEP access within a community-based LGBTQ+ testing center	6
Use of doravirine-based regimens in clinical practice in Europe	6
Development of Frail RISC-HIV: a Risk Score for Predicting Frailty Risk in the Short-term for Care of People with HIV	6
Fracture prevalence and its association with bone density among children living with HIV in Zimbabwe	6
Variability in the relationships between auditory processing and neurocognitive status among older adults with HIV	6